Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 11 | 2024 | 608 | 2.220 |
Why?
|
| Fontan Procedure | 3 | 2023 | 186 | 1.150 |
Why?
|
| Pulmonary Veins | 2 | 2024 | 172 | 0.910 |
Why?
|
| Heart Defects, Congenital | 8 | 2024 | 1832 | 0.910 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 24 | 0.850 |
Why?
|
| Angioplasty, Balloon | 1 | 2024 | 127 | 0.800 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2023 | 142 | 0.720 |
Why?
|
| India | 13 | 2025 | 224 | 0.700 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 210 | 0.700 |
Why?
|
| Stents | 3 | 2024 | 731 | 0.640 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 1993 | 0.600 |
Why?
|
| Upper Extremity | 1 | 2019 | 52 | 0.580 |
Why?
|
| Ambulatory Care | 2 | 2018 | 386 | 0.570 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 66 | 0.570 |
Why?
|
| Echocardiography | 6 | 2025 | 1093 | 0.530 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 124 | 0.530 |
Why?
|
| Atherosclerosis | 6 | 2024 | 932 | 0.520 |
Why?
|
| Heart Failure | 6 | 2025 | 2141 | 0.510 |
Why?
|
| Dyslipidemias | 3 | 2024 | 228 | 0.470 |
Why?
|
| Anticholesteremic Agents | 3 | 2022 | 222 | 0.470 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2022 | 699 | 0.450 |
Why?
|
| Teleradiology | 1 | 2014 | 6 | 0.450 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2024 | 124 | 0.450 |
Why?
|
| Computer-Assisted Instruction | 1 | 2014 | 53 | 0.430 |
Why?
|
| Bisoprolol | 2 | 2024 | 9 | 0.430 |
Why?
|
| User-Computer Interface | 1 | 2014 | 155 | 0.410 |
Why?
|
| Radiology | 1 | 2014 | 110 | 0.400 |
Why?
|
| Educational Measurement | 1 | 2014 | 268 | 0.380 |
Why?
|
| Consensus | 6 | 2024 | 607 | 0.370 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 445 | 0.370 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 57 | 0.360 |
Why?
|
| Cholesterol, LDL | 6 | 2024 | 585 | 0.350 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 296 | 0.350 |
Why?
|
| Exercise Test | 1 | 2012 | 240 | 0.340 |
Why?
|
| Stroke Volume | 4 | 2025 | 489 | 0.320 |
Why?
|
| Humans | 44 | 2025 | 124973 | 0.310 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 74 | 0.300 |
Why?
|
| Septal Occluder Device | 2 | 2023 | 46 | 0.290 |
Why?
|
| Treatment Outcome | 9 | 2024 | 12233 | 0.290 |
Why?
|
| Clinical Competence | 1 | 2014 | 969 | 0.270 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2023 | 125 | 0.270 |
Why?
|
| Neprilysin | 2 | 2024 | 18 | 0.270 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 2 | 2024 | 14 | 0.270 |
Why?
|
| Ventricular Function, Left | 3 | 2025 | 503 | 0.250 |
Why?
|
| Hypertension, Pulmonary | 2 | 2022 | 442 | 0.250 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 996 | 0.250 |
Why?
|
| Heart Ventricles | 2 | 2025 | 745 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 349 | 0.240 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2009 | 283 | 0.240 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2014 | 138 | 0.240 |
Why?
|
| Heart Murmurs | 1 | 2005 | 12 | 0.230 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 699 | 0.230 |
Why?
|
| Male | 16 | 2025 | 61670 | 0.230 |
Why?
|
| Vascular Closure Devices | 1 | 2024 | 9 | 0.220 |
Why?
|
| Splenic Vein | 1 | 2024 | 11 | 0.220 |
Why?
|
| Hepatic Veins | 1 | 2024 | 20 | 0.220 |
Why?
|
| Retrospective Studies | 8 | 2025 | 16569 | 0.220 |
Why?
|
| Female | 15 | 2025 | 67493 | 0.210 |
Why?
|
| Dihydropyridines | 1 | 2024 | 7 | 0.210 |
Why?
|
| Angiography | 1 | 2024 | 181 | 0.210 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 107 | 0.210 |
Why?
|
| Child | 10 | 2024 | 25038 | 0.200 |
Why?
|
| Length of Stay | 2 | 2019 | 1291 | 0.200 |
Why?
|
| Child, Preschool | 5 | 2024 | 14341 | 0.190 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2023 | 167 | 0.180 |
Why?
|
| Infant | 5 | 2024 | 12733 | 0.180 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2022 | 116 | 0.170 |
Why?
|
| Preoperative Care | 1 | 2023 | 342 | 0.170 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 172 | 0.170 |
Why?
|
| Apolipoproteins B | 1 | 2020 | 140 | 0.160 |
Why?
|
| Tuberous Sclerosis | 1 | 2021 | 121 | 0.160 |
Why?
|
| Heart Injuries | 1 | 2020 | 49 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 61 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2022 | 779 | 0.160 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 64 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 222 | 0.160 |
Why?
|
| Adolescent | 7 | 2024 | 19921 | 0.160 |
Why?
|
| Pulmonary Valve | 1 | 2020 | 88 | 0.150 |
Why?
|
| Adult | 8 | 2022 | 30051 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2022 | 249 | 0.150 |
Why?
|
| Lipoprotein(a) | 1 | 2020 | 130 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 183 | 0.150 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 146 | 0.150 |
Why?
|
| Cholesterol, HDL | 4 | 2020 | 372 | 0.150 |
Why?
|
| Balloon Valvuloplasty | 2 | 2020 | 22 | 0.150 |
Why?
|
| Fluoroscopy | 1 | 2019 | 93 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 111 | 0.150 |
Why?
|
| Radiation Dosage | 1 | 2019 | 125 | 0.140 |
Why?
|
| Operative Time | 1 | 2019 | 190 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2022 | 480 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 149 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 432 | 0.140 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 280 | 0.130 |
Why?
|
| Proprotein Convertase 9 | 3 | 2022 | 81 | 0.130 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2017 | 18 | 0.130 |
Why?
|
| Pericarditis, Constrictive | 1 | 2017 | 6 | 0.130 |
Why?
|
| Risk Factors | 8 | 2024 | 10275 | 0.130 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2017 | 24 | 0.130 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 22 | 0.130 |
Why?
|
| Aorta | 1 | 2020 | 503 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2019 | 763 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 397 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2020 | 800 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 735 | 0.120 |
Why?
|
| Hypertension | 1 | 2024 | 1272 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1222 | 0.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 536 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2021 | 615 | 0.110 |
Why?
|
| Brachiocephalic Veins | 1 | 2014 | 13 | 0.110 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2014 | 40 | 0.110 |
Why?
|
| Mitral Valve Stenosis | 1 | 2014 | 34 | 0.110 |
Why?
|
| Subclavian Artery | 1 | 2014 | 66 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 995 | 0.100 |
Why?
|
| Internationality | 1 | 2014 | 129 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1338 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 3555 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 163 | 0.100 |
Why?
|
| Anaerobic Threshold | 1 | 2012 | 10 | 0.090 |
Why?
|
| Pulmonary Ventilation | 1 | 2012 | 31 | 0.090 |
Why?
|
| Time Factors | 2 | 2020 | 5987 | 0.090 |
Why?
|
| Cardiology | 1 | 2017 | 470 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 86 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3254 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1811 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8324 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 537 | 0.080 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 388 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2012 | 762 | 0.080 |
Why?
|
| Tetralogy of Fallot | 1 | 2012 | 171 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1620 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2555 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 461 | 0.080 |
Why?
|
| Kinetics | 1 | 2012 | 1088 | 0.080 |
Why?
|
| Curriculum | 1 | 2014 | 749 | 0.080 |
Why?
|
| Heart Rate | 1 | 2012 | 563 | 0.070 |
Why?
|
| Lipids | 2 | 2024 | 541 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 968 | 0.070 |
Why?
|
| Pediatrics | 1 | 2017 | 1206 | 0.070 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 121 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2009 | 502 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5042 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1957 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2022 | 2160 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2022 | 6133 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1116 | 0.050 |
Why?
|
| Electrocoagulation | 1 | 2023 | 32 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2024 | 3389 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 143 | 0.050 |
Why?
|
| Anthracyclines | 1 | 2022 | 43 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2023 | 64 | 0.050 |
Why?
|
| Cardiotoxicity | 1 | 2022 | 40 | 0.050 |
Why?
|
| Dicarboxylic Acids | 1 | 2022 | 34 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 247 | 0.050 |
Why?
|
| Ezetimibe | 1 | 2022 | 90 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2023 | 264 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 124 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 220 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2005 | 947 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 343 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 9535 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 474 | 0.040 |
Why?
|
| Pregnancy | 1 | 2012 | 7327 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2020 | 171 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2020 | 214 | 0.040 |
Why?
|
| Patients | 1 | 2020 | 121 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 318 | 0.040 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 118 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 1518 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 2019 | 185 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 641 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2560 | 0.040 |
Why?
|
| Triglycerides | 1 | 2020 | 590 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1213 | 0.030 |
Why?
|
| Cholesterol | 1 | 2020 | 539 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2020 | 594 | 0.030 |
Why?
|
| Life Style | 1 | 2020 | 428 | 0.030 |
Why?
|
| Incidence | 1 | 2005 | 3157 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 690 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 2921 | 0.030 |
Why?
|
| Communication | 1 | 2020 | 505 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2019 | 342 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 283 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 27074 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 996 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 2010 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 233 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1509 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 1506 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3115 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4296 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 5908 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 19830 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2004 | 154 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11095 | 0.010 |
Why?
|